Keros Therapeutics

KROS

Market cap $523M

Buy

Hold

Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$21

24% upside

High target

positive

2 neutral

50%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
BofA Securities Jason Zemansky				28 Nov ‘25 3 days ago
Oppenheimer Andreas Argyrides 67% 1-yr KROS win rate				12 Nov ‘25 19 days ago
Wells Fargo Benjamin Burnett 100% 1-yr KROS win rate				11 Nov ‘25 20 days ago
Wedbush Yun Zhong				6 Nov ‘25 25 days ago